Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Sidi Mohamed El Amine Benlazar: CPX-351 and Ruxolitinib in Advanced-Phase Myeloproliferative Neoplasms
Sidi Mohamed El Amine Benlazar/X
Sep 12, 2026, 17:43

Sidi Mohamed El Amine Benlazar: CPX-351 and Ruxolitinib in Advanced-Phase Myeloproliferative Neoplasms

Sidi Mohamed El Amine Benlazar, Professor of Hematology, Head of the Hospitalization and Geriatric Unit at the University Hospital of Sidi Bel Abbès, shared a post on X about a recent article by Shivani Handa et al., published in Blood Neoplasia, adding:

“CPX-351 in combination with ruxolitinib for advanced-phase myeloproliferative neoplasms: results of a phase 1 study”

Title: CPX-351 in combination with ruxolitinib for advanced-phase myeloproliferative neoplasms: results of a phase 1 study

Authors: Shivani Handa, Yazan Madanat, Kelly Pugh, Kaitlyn Dvorak-Kornaus, Qiuhong Zhao, Alice Mims, Kristin Koenig, Andrew Srisuwananukorn, Rachel Cook, Ronan Swords, Uma Borate

Sidi Mohamed El Amine Benlazar

Stay updated on all scientific advances with Hemostasis Today.

Alice Mims Andrew Srisuwananukorn Blood Blood Neoplasia CPX-351 Health Hematology Hemostasis Hemostasis News Hemostasis Today Kaitlyn Dvorak-Kornaus Kelly Pugh Kristin Koenig Medicine myeloproliferative neoplasms Qiuhong Zhao Rachel Cook Ronan Swords ruxolitinib Shivani Handa Sidi Mohamed El Amine Benlazar Uma Borate Yazan Madanat
NewsFeed